Molecular mechanisms of hyperalphalipoproteinemia / Shizuya Yamashita, Daisaku Masuda, Tohru Ohama and Masahiro Koseki -- CETP deficiency and concerns in CETP inhibitor development / Akhiro Inazu -- Degenerated HDL and its clinical implications / Hirokazu Honda, Toshiyuki Matsunaga and Tsugikazu Komoda -- HDL Apoprotein mimetic peptides as antiinflammatory molecules / Godfrey S. Getz and Catherine A. Reardon -- Reverse cholesterol transport in HDL metabolism / Maryse Guerin -- Role of ATP-Binding cassette transporters A1 and G1 in reverse cholesterol transport in altherosclerosis / Kazuhiro Nakaya, Makoto Ayaori and Katsunori Ikewaki -- Sphingosin-1-phosphate and HDL metabolism / Xian-Cheng Jiang and Zhiqiang Li -- Role of SR-BI in HDL metabolism / Herbert Stangl and Witta Monika Strobl -- Paroxonase 1 and its clinical relevance / Alejandro Gugliucci -- MicroRNA regulation of HDL homeostasis / Xinghui Sun and Mark W. Feinberg -- The application of proteomic techniques in the study of HDL particle characterization and biomarker discovery / Elena Burillo, Inmaculada Jorge, Diego Martínez-López, Emilio Camafeita, Jesus Vazquez and Jose L. Martin-Ventura -- Therapies targeting HDLc levels and HDL function / Cecelia Vitali and Marina Cuchel. |